What is the role of mineralocorticoid receptor antagonists in chronic kidney disease?
Research has shown that mineralocorticoid receptor antagonists can reduce proteinuria and slow the progression of chronic kidney disease. A systematic review and meta-analysis of studies conducted in 2016 concluded that these medications can be an effective treatment for chronic kidney disease, although further research is needed to determine their exact role in treating the condition.